TO treat conditions such as type-1 diabetes in mice. Stem cells are cells that can be developed in other cell types. Embryonic stem cells can develop into different cell types are more widespread.
In lab tests conducted on mice, scientists at the San Diego company called Novocell move human embryonic stem cells to fat in the abdomen of mice. Before implanted into mice, stem cells have been prepared to develop into pancreatic cells that have been killed by a type-1 diabetes.
In the site webMD.com say, thirty days after the implantation, embryonic stem cells had been transformed into cells of the pancreas. And about two months later, the cells of the pancreas begins to produce insulin, a hormone that regulates blood sugar.
Experience has shown the potential for embryonic stem cells to treat type-1 diabetes, the researchers noted, one of which is Emmanuel Baetge, PhD. But the process was still not ready for use in humans.
Of the 46 transfers that Baetge team transplanted into mice, seven cause tumors. Scientists worldwide are working on ways to use the potential of stem cells and minimize health risks of treatment with stem cells. Baetge and his colleagues reported their findings in Nature Biotechnology.
No comments:
Post a Comment